Literature DB >> 107957

Intracytoplasmic type A particles from mammary tumours and leukaemias of strain ICRC mice.

K A Karande, B J Joshi, V R Talageri, R U Dumaswala, K J Ranadive.   

Abstract

The ovarian-hormone-induced leukaemias of strain ICRC mice, with an abundance of intracytoplasmic type A particles in primary as well as transplanted lesions, were used to study morphological, biophysical, immunological and structural characteristics of type A particles. Mammary tumours of strains ICRC and C3H(Jax) were also used as sources for type A particles. The purified virions banded at the density of 1.20 g/ml in 12--60% linear sucrose-density gradient when subjected to spinning at 113,000 g for 4 h. The SDS-polyacrylamide-gel electrophoresis of type A particles from mammary tumours and leukaemias reproducibly resolved at least 8 polypeptides, 2 of these 54,000 and 24,000 dalton proteins, showing variable expression. Type A particles and B particles, despite the fact that each had a distinct polypeptide pattern, showed common antigens with different electrophoretic mobilities. Proteins of 24,000, 18,000 and 12,000 daltons from B particles were found to be antigenically related to those from type A particles. The bioassay studies carried out with purified A particles showed that 2/7 males of strain ICRC and 1/6 females of strain DBA-MTI developed leukaemias, as against none in the controls, when inoculated between the ages of 1-7 days. Spleen tumour and cervical tumour were seen in one female each of strain DBA-MTI.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 107957      PMCID: PMC2009847          DOI: 10.1038/bjc.1979.23

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  ML: A NEW ANTIGEN FOUND IN LEUKAEMIAS AND MAMMARY TUMOURS OF THE MOUSE.

Authors:  B STUECK; E A BOYSE; L J OLD; E A CARSWELL
Journal:  Nature       Date:  1964-09-05       Impact factor: 49.962

2.  THE MAMMARY TUMOR AGENT IN COMPLETELY MAMMECTOMIZED MICE.

Authors:  A DUX; O MUEHLBOCK
Journal:  Proc Soc Exp Biol Med       Date:  1964-02

3.  Elimination of substances interfering with nucleic acids estimation.

Authors:  M DE DEKEN-GRENSON; R H DE DEKEN
Journal:  Biochim Biophys Acta       Date:  1959-01

4.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

5.  Measurement of cell growth in tissue culture with a phenol reagent (folin-ciocalteau).

Authors:  V I OYAMA; H EAGLE
Journal:  Proc Soc Exp Biol Med       Date:  1956-02

6.  Mouse mammary tumor virus polypeptide precursors in intracytoplasmic A particles.

Authors:  G H Smith; B K Lee
Journal:  J Natl Cancer Inst       Date:  1975-08       Impact factor: 13.506

7.  Characterisation of mammary tumour virus of strain ICRC mouse.

Authors:  K A Karande; B J Joshi; V R Talageri; R U Dumaswala; K J Ranadive
Journal:  Eur J Cancer       Date:  1978-03       Impact factor: 9.162

8.  Electron microscopy of tumor cells and tumor viruses; a review.

Authors:  W BERNHARD
Journal:  Cancer Res       Date:  1958-06       Impact factor: 12.701

9.  Activation of murine leukaemia virus under different physiological conditions.

Authors:  K A Karande; S P Taskar; K J Ranadive
Journal:  Br J Cancer       Date:  1975-04       Impact factor: 7.640

10.  Electron microscopy of plasma-cell tumors of the mouse. I. MPC-1 and X5563 tumors.

Authors:  D F PARSONS; E B DARDEN; D L LINDSLEY; G T PRATT
Journal:  J Biophys Biochem Cytol       Date:  1961-02
View more
  2 in total

1.  Integration of type B retroviral DNA in virus-induced primary murine thymic lymphomas.

Authors:  G A Dekaban; J K Ball
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

2.  ML antigen of DBA/2 mouse leukemias: expression of an endogenous murine mammary tumor virus.

Authors:  J Racevskis; N H Sarkar
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.